Dec 29 (Reuters) - Ultragenyx Pharmaceutical said on Monday that its experimental drug for a type of genetic bone disease did not meet the main goal in late-stage studies. The company was testing the ...
That unmistakable sound of bone giving way under pressure sends immediate dread through anyone who hears it. Broken bones account for millions of medical visits annually in the United States alone, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback